FIELD: medicine.
SUBSTANCE: invention relates to inhibitors used for applying in hemostasis and immune reactions. Such inhibitors are members of the protein family carrying collagen-like and globular domains, namely different sequences zig 37. These inhibitors are useful for blood stream stimulation in vascular net by reducing thrombogenic activity and activity of complement and for recovery of collagen surfaces and modulation in wounds healing also. The advantage of invention involves the acceleration of repairing injured vessels.
EFFECT: valuable medicinal properties of inhibitors.
66 cl, 8 dwg, 25 ex
Title | Year | Author | Number |
---|---|---|---|
ISOLATED POLYPEPTIDE SHOWING HOMOLOGY RELATIVELY TO COMPLEMENT-RELATED ADIPOCYTE PROTEIN (VARIANTS), HYBRID PROTEIN (VARIANTS), EXPRESSING VECTOR, METHOD FOR PREPARING POLYPEPTIDE, POLYCLONAL ANTIBODY, FRAGMENT OF ISOLATED POLYNUCLEOTIDE (VARIANTS) | 1998 |
|
RU2218402C2 |
INTERFERON-LIKE PROTEIN ZCYTO21 | 2001 |
|
RU2292394C2 |
AFFINITY-MATURED CRIG VERSIONS | 2009 |
|
RU2553517C2 |
METHODS OF TREATING CONDITIONS ASSOCIATED WITH MASP-2-DEPENDENT COMPLEMENT ACTIVATION | 2014 |
|
RU2718850C2 |
ANTI-INTEGRIN ALPHA-2 ANTIBODIES AND USING THEM | 2011 |
|
RU2545401C2 |
DECREASING B-CELL COUNT WITH USING CD37-SPECIFIC AND CD20-SPECIFIC BINDING MOLECULES | 2006 |
|
RU2423381C2 |
ANTIBODY Fc VARIANTS | 2012 |
|
RU2607014C2 |
THERAPEUTIC POLYPEPTIDES, HOMOLOGUES THEREOF, FRAGMENTS THEREOF AND APPLICATION THEREOF FOR MODULATION OF PLATELET-MEDIATED AGGREGATION | 2004 |
|
RU2524129C2 |
MONOCLONAL ANTIBODIES AGAINST PROTEIN RGM A AND APPLICATION THEREOF | 2009 |
|
RU2524136C2 |
METHODS OF TREATING CONDITIONS ASSOCIATED WITH MASP-2 DEPENDENT COMPLEMENT ACTIVATION | 2012 |
|
RU2743409C2 |
Authors
Dates
2004-11-10—Published
2000-02-17—Filed